Director Shareholding
Phytopharm PLC
6 January 2004
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) NAME OF COMPANY
PHYTOPHARM PLC
2) NAME OF DIRECTOR
DR R P DIXEY
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder
if it is a holding of that person's spouse or children under the
age of 18 or in respect of an non-beneficial interest
AS 2 ABOVE
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them. (If notified)
AS 2 ABOVE
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
AS 2 ABOVE
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
GRANT OF SHARE OPTIONS UNDER THE PHYTOPHARM SHARE OPTION PLAN 2003
7) Number of shares/amount of stock acquired
8) Percentage of issued Class
9) Number of shares/amount
of stock disposed
10) Percentage of issued Class
(any treasury shares held by company should not be taken into account when
calculating percentage)
11) Class of security
12) Price per share
13) Date of transaction
14) Date company informed
15) Total holding following this notification
16) Total percentage holding of issued class following this notification
IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
COMPLETE THE FOLLOWING BOXES
17) Date of grant
9 DECEMBER 2003
18) Period during which or date on which exercisable
10 DECEMBER 2006 TO 9 DECEMBER 2013 SUBJECT TO PERFORMANCE CRITERIA
19) Total amount paid (if any) for grant of the option
NIL
20) Description of shares or debentures involved: class, number.
51,249 PHYTOPHARM PLC ORDINARY 1 PENCE SHARES
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
212.5 PENCE
22) Total number of shares or debentures over which options held
following this notification
595,509
23) Any additional information
PERFORMANCE CRITERIA ARE BASED ON TOTAL SHAREHOLDER RETURN COMPARED TO
COMPARATOR GROUPS AT THE THIRD, FOURTH AND FIFTH ANNIVERSARIES OF GRANT. NO
OPTIONS VEST FOR BELOW MEDIAN PERFORMANCE, 25% VEST FOR MEDIAN PERFORMANCE
AND 100% VEST FOR UPPER DECILE AND ABOVE WITH PRORATE VESTING BETWEEN
MEDIAN AND UPPER DECILE PERFORMANCE. FOR 34,168 OPTIONS THE COMPARATOR
GROUP COMPRISES 19 OTHER UK LISTED BIOTECH COMPANIES, AND FOR 17,081
OPTIONS THE COMPARATOR GROUP IS THE FTSE SMALL CAP INDEX
24) Name of contact and telephone number for queries
DR G W CHONG
1480 437697
25) Name and signature of authorised company official responsible for
making this notification
Date of Notification 6 JANUARY 2004
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) NAME OF COMPANY
PHYTOPHARM PLC
2) NAME OF DIRECTOR
DR D D REES
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder
if it is a holding of that person's spouse or children under the
age of 18 or in respect of an non-beneficial interest
AS 2 ABOVE
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them. (If notified)
AS 2 ABOVE
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
AS 2 ABOVE
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
GRANT OF SHARE OPTIONS UNDER THE PHYTOPHARM SHARE OPTION PLAN 2003
7) Number of shares/amount of stock acquired
8) Percentage of issued Class
9) Number of shares/amount
of stock disposed
10) Percentage of issued Class
(any treasury shares held by company should not be taken into account when
calculating percentage)
11) Class of security
12) Price per share
13) Date of transaction
14) Date company informed
15) Total holding following this notification
16) Total percentage holding of issued class following this notification
IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
COMPLETE THE FOLLOWING BOXES
17) Date of grant
9 DECEMBER 2003
18) Period during which or date on which exercisable
10 DECEMBER 2006 TO 9 DECEMBER 2013 SUBJECT TO PERFORMANCE CRITERIA
19) Total amount paid (if any) for grant of the option
NIL
20) Description of shares or debentures involved: class, number.
62,304 PHYTOPHARM PLC ORDINARY 1 PENCE SHARES
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
212.5 PENCE
22) Total number of shares or debentures over which options held
following this notification
621,318
23) Any additional information
PERFORMANCE CRITERIA ARE BASED ON TOTAL SHAREHOLDER RETURN COMPARED TO
COMPARATOR GROUPS AT THE THIRD, FOURTH AND FIFTH ANNIVERSARIES OF GRANT. NO
OPTIONS VEST FOR BELOW MEDIAN PERFORMANCE, 25% VEST FOR MEDIAN PERFORMANCE
AND 100% VEST FOR UPPER DECILE AND ABOVE WITH PRORATE VESTING BETWEEN
MEDIAN AND UPPER DECILE PERFORMANCE. FOR 41,538 OPTIONS THE COMPARATOR
GROUP COMPRISES 19 OTHER UK LISTED BIOTECH COMPANIES, AND FOR 20,766
OPTIONS THE COMPARATOR GROUP IS THE FTSE SMALL CAP INDEX
24) Name of contact and telephone number for queries
DR G W CHONG
1480 437697
25) Name and signature of authorised company official responsible for
making this notification
Date of Notification 6 JANUARY 2004
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1) NAME OF COMPANY
PHYTOPHARM PLC
2) NAME OF DIRECTOR
DR G W CHONG
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder
if it is a holding of that person's spouse or children under the
age of 18 or in respect of an non-beneficial interest
AS 2 ABOVE
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them. (If notified)
AS 2 ABOVE
5) Please state whether notification relates to a person(s) connected
with the Director named in 2 above and identify the connected person(s)
AS 2 ABOVE
6) Please state the nature of the transaction. For PEP transactions
please indicate whether general/single co PEP and if discretionary/non
discretionary
GRANT OF SHARE OPTIONS UNDER THE PHYTOPHARM SHARE OPTION PLAN 2003
7) Number of shares/amount of stock acquired
8) Percentage of issued Class
9) Number of shares/amount
of stock disposed
10) Percentage of issued Class
(any treasury shares held by company should not be taken into account when
calculating percentage)
11) Class of security
12) Price per share
13) Date of transaction
14) Date company informed
15) Total holding following this notification
16) Total percentage holding of issued class following this notification
IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
COMPLETE THE FOLLOWING BOXES
17) Date of grant
9 DECEMBER 2003
18) Period during which or date on which exercisable
10 DECEMBER 2006 TO 9 DECEMBER 2013 SUBJECT TO PERFORMANCE CRITERIA
19) Total amount paid (if any) for grant of the option
NIL
20) Description of shares or debentures involved: class, number.
35,124 PHYTOPHARM PLC ORDINARY 1 PENCE SHARES
21) Exercise price (if fixed at time of grant) or indication that price
is to be fixed at time of exercise
212.5 PENCE
22) Total number of shares or debentures over which options held
following this notification
145,932
23) Any additional information
PERFORMANCE CRITERIA ARE BASED ON TOTAL SHAREHOLDER RETURN COMPARED TO
COMPARATOR GROUPS AT THE THIRD, FOURTH AND FIFTH ANNIVERSARIES OF GRANT. NO
OPTIONS VEST FOR BELOW MEDIAN PERFORMANCE, 25% VEST FOR MEDIAN PERFORMANCE
AND 100% VEST FOR UPPER DECILE AND ABOVE WITH PRORATE VESTING BETWEEN
MEDIAN AND UPPER DECILE PERFORMANCE. FOR 23,418 OPTIONS THE COMPARATOR
GROUP COMPRISES 19 OTHER UK LISTED BIOTECH COMPANIES, AND FOR 11,706
OPTIONS THE COMPARATOR GROUP IS THE FTSE SMALL CAP INDEX
24) Name of contact and telephone number for queries
DR G W CHONG
1480 437697
25) Name and signature of authorised company official responsible for
making this notification
Date of Notification 6 JANUARY 2004
This information is provided by RNS
The company news service from the London Stock Exchange
Monday, 13th May 2024
COMPANIES COVERED:
Latest directors dealings
- 9 minutes ago easyJet
- 54 minutes ago Oxford Instruments
- 1 hour ago Sabre Insurance Group
- 2 hours ago Moneysupermarket.com Group
- 2 hours ago BioPharma Credit